|

货币单位:美元(USD)

Immunomedics, Inc. (immu)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Andrew D. Dickinson	Andrew D. Dickinson is currently serving as the President, Treasurer & Director at Immunomedics, Inc. He is also a Director at Sutter Health and Forty Seven, Inc. Additionally, he holds positions as a Director at Fosun Kite Biotechnology Co., Ltd. and Gilead Sciences Ltd. In the future, he will be a Non-Independent Non-Executive Director at Galapagos NV and the President, Treasurer & Director at CymaBay Therapeutics, Inc. Previously, he worked as the Chief Financial Officer at Gilead Sciences, Inc. He has also held positions as the Secretary, Vice President & General Counsel at Gilead Colorado, Inc. and as the Co-Head-Healthcare Investment Banking at Lazard, Inc. Prior to that, he was a Founding Partner at Kendall Dickinson & Koenig LLC. Mr. Dickinson completed his graduate degree at Loyola University of Chicago in 1996 and his undergraduate degree at The University of Colorado in 1993.

Andrew D. Dickinson

Andrew D. Dickinson is currently serving as the President, Treasurer & Director at Immunomedics, Inc. He is also a Director at Sutter Health and Forty Seven, Inc. Additionally, he holds positions as a Director at Fosun Kite Biotechnology Co., Ltd. and Gilead Sciences Ltd. In the future, he will be a Non-Independent Non-Executive Director at Galapagos NV and the President, Treasurer & Director at CymaBay Therapeutics, Inc. Previously, he worked as the Chief Financial Officer at Gilead Sciences, Inc. He has also held positions as the Secretary, Vice President & General Counsel at Gilead Colorado, Inc. and as the Co-Head-Healthcare Investment Banking at Lazard, Inc. Prior to that, he was a Founding Partner at Kendall Dickinson & Koenig LLC. Mr. Dickinson completed his graduate degree at Loyola University of Chicago in 1996 and his undergraduate degree at The University of Colorado in 1993.